The CHF trial had along follow period comparing the two trials is confusing the issue probably as an attempt to safe face on your part.
30 day follow up and 60 follow up for the Covid Trial ARDS. The first 30% possibly the first 45% group already had 60 day follow up.
Exactly @eyeswideopen ... comparing CHF follow up with the COVID-19 ARDS trial follow up is ridiculous .... anywhoo @Ratfink seems to think his analogies are the only correct ones so I am not bothering to reply anymore on the matter.... it could go wither way and until we see the data we are all just speculating !
Oh and @Pooslice .... LMAO
As many know on here and through platforms other than here, all free carry for me and I sold 20%+ of those free carry shares in the lead up to the FDA decision on Ryoncil for $5.20 for the reasons I outlined on here in the lead up to that decision, so yes it would seem a little smarter than you who bought high, took a punt and lost money - just sayin'
Do you still think Mesoblast will be the next CSL?, page-65
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.61 |
Change
0.033(2.06%) |
Mkt cap ! $1.832B | |||
| Open | High | Low | Value | Volume |
| $1.65 | $1.65 | $1.59 | $6.050M | 3.741M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 22 | 20800 | $1.61 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.61 | 5452 | 11 |
View Market Depth
| Last trade - 15.09pm 19/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |